The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016
Open accessAbstract
These clinical guidelines have been developed to assist in the management of patients presenting with chest pain suspected to be due to an acute coronary syndrome (ACS) and those with confirmed ACS. These guidelines should be read in conjunction with the ACS Clinical Care Standards developed by the Australian Commission for Safety and Quality in Health Care (ACSQHC) [[1]Australian Commission on Safety and Quality in Health Care. Acute Coronary Syndromes Clinical Care Standard. 2014. Available at: http://www.safetyandquality.gov.au/our-work/clinical-care-standards/acute-coronary-syndromes-clinical-care-standard/. Accessed 30/3/16Google Scholar] and the Australian acute coronary syndromes capability framework developed by the Heart Foundation [[2]National Heart Foundation of Australia. Australian acute coronary syndromes capability framework. 2015. Available at: https://heartfoundation.org.au/for-professionals/clinical-information/acute-coronary-syndromes. Accessed 30/3/16.Google Scholar]. Additional guidance around the timing and use of therapies is detailed in the accompanying practice advice. Tabled 1RecommendationGRADE strength of recommendationNHMRC Level of Evidence (LOE)Initial assessment of chest painIt is recommended that a patient with acute chest pain or other symptoms suggestive of an ACS receives a 12-lead ECG and this ECG is assessed for signs of myocardial ischaemia by an ECG-experienced clinician within 10 minutes of first acute clinical contact.StrongIIICA patient presenting with acute chest pain or other symptoms suggestive of an ACS should receive care guided by an evidence-based Suspected ACS Assessment Protocol (Suspected ACS-AP) that includes formal risk stratification.StrongIAUsing serial sampling, cardiac-specific troponin levels should be measured at hospital presentation and at clearly defined periods after presentation using a validated Suspected ACS-AP in patients with symptoms of possible ACS.StrongIANon-invasive objective testing is recommended in intermediate-risk patients, as defined by a validated Suspected ACS-AP, with normal serial troponin and ECG testing and who remain symptom-free.WeakIAPatients in whom no further objective testing for coronary artery disease (CAD) is recommended are those at low risk, as defined by a validated Suspected ACS-AP: age <40 years, symptoms atypical for angina, in the absence of known CAD, with normal troponin and ECG testing, and who remain symptom-free.WeakIII-3CDiagnostic considerations and risk stratification ofThe routine use of validated risk stratification tools for ischaemic and bleeding events (e.g. GRACE score for ischaemic risk or CRUSADE score for bleeding risk) may assist in patient-centric clinical decision-making in regards to ACS care.WeakIIIBAcute reperfusion and invasive management strategies in ACSFor patients with ST elevation myocardial infarction (STEMI) presenting within 12 hours of symptom onset, and in the absence of advanced age, frailty and comorbidities that influence the individual's overall survival, emergency reperfusion therapy with either primary percutaneous coronary intervention (PCI) or fibrinolytic therapy is recommended.StrongIAPrimary PCI is preferred for reperfusion therapy in patients with STEMI if it can be performed within 90 minutes of first medical contact; otherwise fibrinolytic therapy is preferred for those without contra-indications.StrongIAAmong patients treated with fibrinolytic therapy who are not in a PCI-capable hospital, early or immediate transfer to a PCI-capable hospital for angiography, and PCI if indicated, within 24 hours is recommended.WeakIIAAmong patients treated with fibrinolytic therapy, for those with ≤50% ST recovery at 60–90 minutes, and/or with haemodynamic instability, immediate transfer for angiography with a view to rescue angioplasty is recommended.StrongIBAmong high- and very high-risk patients with non-ST elevation acute coronary syndromes (NSTEACS) (except Type 2 MI), a strategy of angiography with coronary revascularisation (PCI or coronary artery bypass grafts) where appropriate is recommended.StrongIAPatients with NSTEACS who have no recurrent symptoms and no risk criteria are considered at low risk of ischaemic events, and can be managed with a selective invasive strategy guided by provocative testing for inducible ischaemia.StrongIATiming of invasive management for NSTEACSVery high-risk patients: Among patients with NSTEACS with very high-risk criteria (ongoing ischaemia, haemodynamic compromise, arrhythmias, mechanical complications of MI, acute heart failure, recurrent dynamic or widespread ST-segment and/or T-wave changes on ECG), an immediate invasive strategy is recommended (i.e. within 2 hours of admission).StrongIICHigh-risk patients: In the absence of very high-risk criteria, for patients with NSTEACS with high-risk criteria (GRACE score >140, dynamic ST-segment and/or T-wave changes on ECG, or rise and/or fall in troponin compatible with MI) an early inv
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Authors/Task Force Members, Steg, P. G., James, S. K., Atar, D., Badano, L. P., Lundqvist, C. B., Borger, M. A., Di Mario, C., Dickstein, K., Ducrocq, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs215 · Cited by 6,829
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., Darius, H., Lewis, B. S., Ophuis, T. O., Jukema, J. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410489 · Cited by 4,487
Keeley, E. C., Boura, J. A., & Grines, C. L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12113-7 · Cited by 4,361
Antman, E. M., Cohen, M., Bernink, P. J. L. M., McCabe, C. H., Horacek, T., Papuchis, G., Mautner, B., Corbalan, R., Radley, D., & Braunwald, E. (2000) · JAMA · doi:10.1001/jama.284.7.835 · Cited by 3,242
Cited by
The role of cardiac rehabilitation in improving cardiovascular outcomes
Taylor, R. S., Dalal, H. M., & McDonagh, S. T. J. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00611-7 · Cited by 570
Redfern, J., Coorey, G., Mulley, J., Scaria, A., Neubeck, L., Hafiz, N., Pitt, C., Weir, K., Forbes, J., Parker, S., et al. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-00325-z · Cited by 95
Nicholls, S. J., Nelson, M., Astley, C., Briffa, T., Brown, A., Clark, R., Colquhoun, D., Gallagher, R., Hare, D. L., Inglis, S., et al. (2020) · Heart, Lung and Circulation · doi:10.1016/j.hlc.2020.04.007 · Cited by 43
Self-citationLo, S. T. H., Yong, A. S., Sinhal, A., Shetty, S., McCann, A., Clark, D., Galligan, L., El-Jack, S., Sader, M., Tan, R., et al. (2020) · Heart, Lung and Circulation · doi:10.1016/j.hlc.2020.04.002 · Cited by 28
Self-citation
Metadata
- Authors
- Chew, D. P., Scott, I. A., Cullen, L., French, J. K., Briffa, T. G., Tideman, P. A., Woodruffe, S., Kerr, A., Branagan, M., & Aylward, P. E. G.
- Venue
- Heart, Lung and Circulation
- Publisher
- Elsevier BV
- Published
- 2016-09
- Volume
- 25
- Issue
- 9
- Pages
- 895-951
- ISSN
- 1443-9506 (ISSN-L)
- OpenAlex
- W2460492626
- Cited by
- 314
- References
- 190
- FWCI
- 21.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016. https://app.cochat.ai/papers/10.1016/j.hlc.2016.06.789
- The paper
- Chew, D. P., Scott, I. A., Cullen, L., French, J. K., Briffa, T. G., Tideman, P. A., Woodruffe, S., Kerr, A., Branagan, M., & Aylward, P. E. G. (2016). National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016. Heart, Lung and Circulation. https://doi.org/10.1016/j.hlc.2016.06.789
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.